Mesa Laboratories returns to FY26 profit of $6.71 million; revenue rises 3.4% to $249.13 million

Mesa Laboratories

Mesa Laboratories

MLAB

0.00
  • Mesa Laboratories posted net income of USD 6.71 million, swinging to profit from a loss in fiscal 2026.
  • Revenue rose 3.4% to USD 249.13 million, led by Sterilization and Disinfection Control up 8.7% to USD 101.57 million.
  • Gross margin widened 0.9 percentage points to 63.5%, while operating income increased 13.3% to USD 18.51 million.
  • Clinical Genomics revenue fell 3.6% to USD 45.39 million, while Biopharmaceutical Development was flat at USD 48.63 million.
  • The company expects challenges in China to persist into fiscal 2027, with a substantially smaller financial impact than in fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesa Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000724004-26-000047), on June 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.